System for simulating venous return in a body circulation
By constructing a systemic circulation venous simulation system that includes right ventricular simulation components and arterial compliance simulation components, the problem of insufficient simulation of the right heart system and venous return in the existing technology is solved, a more realistic hemodynamic simulation is achieved, and the system stability and physiological relevance of test results are improved.
Patent Information
- Application Number
- CN202610662147.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-05-14
- Publication Date
- 2026-07-03
AI Technical Summary
Existing extracorporeal circulation testing systems are insufficient in simulating the right heart system and venous return, making it difficult to accurately reflect the hemodynamic behavior of the human venous system under the action of vena cava intervention devices. In particular, when the vena cava is occluded, return is restricted, or there are extreme preload changes, the pressure fluctuations are severe, the system is unstable, and the test results have poor repeatability.
A systemic circulation venous simulation system is constructed by employing a right ventricular simulation component, an arterial blood vessel compliance simulation component, a venous blood vessel module, a damping module, a throttling valve, a collapsible venous segment, a venous blood vessel compliance simulation component, a right atrial simulation component, a drive module, and a data acquisition module. Through graded buffering and damping adjustment, the compliance characteristics and dynamic coupling relationship of the right atrium and venous system are simulated.
It effectively suppressed pressure fluctuations, prevented non-physiological pressure oscillations or negative pressure in the venous system, improved simulation accuracy and system stability, and enhanced the physiological relevance of in vitro testing of vena cava intervention devices.
Smart Images

Figure CN122337086A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of medical device technology, specifically relating to a systemic circulation vein simulation system. Background Technology
[0002] Acute decompensated heart failure and related circulatory dysfunction are common and critical cardiovascular diseases in clinical practice. Their development is often accompanied by complex hemodynamic changes such as decreased cardiac function, restricted venous return, and abnormal fluctuations in central venous pressure. The right atrium, superior and inferior vena cava, and their compliance characteristics play a crucial role in regulating cardiac preload, buffering pressure fluctuations, and preventing excessive right ventricular pumping. Therefore, constructing an in vitro testing platform that can accurately reflect the dynamic characteristics of the human right ventricular and venous system is of great significance for the development of cardiovascular medical devices, in vitro performance evaluation, and related basic research.
[0003] Existing extracorporeal circulation testing systems typically use a combination of pumps, check valves, tubing, and compliant chambers to simulate the basic functions of the heart's pulsation and vascular system. Some systems can achieve relatively good simulations of the left ventricular or arterial systems. However, existing technologies still have significant shortcomings in simulating the right ventricular system and venous return. Specifically, the compliance regulation of the arterial and venous systems is often simplified, and the compliant chamber structure is too simple to simultaneously consider the buffering capacity of pulsatile pressure and system stability. These shortcomings are particularly pronounced when testing under conditions such as vena cava occlusion, restricted return, or extreme preload changes, easily leading to problems such as drastic pressure fluctuations, system instability, or poor repeatability of test results.
[0004] In recent years, a new class of vena cava intervention treatments has emerged for patients with acute decompensated heart failure, such as the preCARDIA system and the Doraya Catheter system. These devices reduce cardiac preload and promote diuresis by intermittently occluding the superior or inferior vena cava, thereby alleviating clinical congestion and related symptoms. While in vitro simulation systems can shorten development time and costs, existing systems still have shortcomings in compliance simulation, reproduction of venous system collapse characteristics, and inhibition of excessive right ventricular aspiration, making it difficult to comprehensively and realistically reflect the hemodynamic behavior of the human venous system under the action of vena cava intervention devices.
[0005] In summary, there is an urgent need for a new systemic venous simulation system that can more realistically simulate the compliance characteristics, flow-limiting characteristics, and dynamic coupling relationship between the right atrium and venous system and right ventricular pulsation, while ensuring stable system operation. This would improve the physiological relevance and reliability of in vitro test results of vena cava intervention devices and guide animal experiments and clinical applications. Summary of the Invention
[0006] The purpose of this invention is to solve the above-mentioned problems and provide a systemic circulation vein simulation system.
[0007] To achieve the above objectives, the present invention adopts the following technical solution: The present invention provides a systemic circulation venous simulation system, which includes a right ventricular simulation component, an arterial compliance simulation component, a venous module, a damping module, a throttle valve, a collapsible venous segment, a venous compliance simulation component, a right atrial simulation component, a drive module, and a data acquisition module. The right ventricular simulation component includes a pulsatile pump, a drive chamber, and a right ventricular model, used to simulate the pumping function of the right ventricle. The arterial compliance simulation component includes a main compliance chamber, a secondary compliance chamber, and a pressure controller. Its upstream portion is connected to the right ventricular simulation component, and its downstream portion is connected to the venous module. This provides volume buffering, simulating the elastic energy storage characteristics of the arterial system and reducing the direct transmission of periodic pressure waves generated by the right ventricle to the downstream circuit. The venous module includes a collecting chamber, a superior vena cava return vessel, an inferior vena cava return vessel, and a vena cava confluence conduit. The upstream portions of the superior vena cava and inferior vena cava return vessels are connected to different outlets of the arterial compliance simulation component via the collecting chamber. The vena cava confluence conduit is connected to the venous compliance simulation component via a collapsible venous segment. The damping module includes a first damping module and a second damping module, respectively located at the two ends of the arterial compliance simulation component connecting the superior vena cava and inferior vena cava return vessels. On each branch, the microcirculatory vascular bed in the simulated venous return path is used to block blood flow. The throttling valve includes a first throttling valve and a second throttling valve, which are respectively set between the first damping module and the venous vessel module to adjust the flow distribution. The collapsible venous segment automatically limits the flow by collapsing itself to prevent excessive negative pressure in the venous system and stabilize the venous return system. The upstream of the venous vessel compliance simulation component is connected to the venous vessel module, and the downstream is connected to the right atrial simulation component to reduce the transmission of right atrial pressure fluctuations to the venous vessels. The right atrial simulation component includes a cavity and a bellows assembly, which reflects the right atrial filling state through internal volume changes to simulate venous blood return. The driving module is used to control the right ventricular simulation component to generate pulsating biomimetic blood flow to simulate cardiac output under different heart failure states. The data acquisition module is used to measure the pressure and flow signals at different preset points in the circulatory loop to evaluate the hemodynamic state of the circulatory system in real time.
[0008] Furthermore, the venous blood vessel compliance simulation component has the same structure as the arterial blood vessel compliance simulation component; the bottom of the main compliance chamber and the auxiliary compliance chamber of the arterial blood vessel compliance simulation component contain test liquid, and the top contains compressible gas; the bottom liquids of the main compliance chamber and the auxiliary compliance chamber are interconnected, and the top air is interconnected, forming a parallel distributed compliance structure; the pressure controller is connected to the auxiliary compliance chamber, and changes the compliance of the arterial blood vessel compliance simulation component and the pressure of the venous blood vessel by adjusting the gas pressure.
[0009] Furthermore, the main compliant cavity is connected to the venous vessel module in two paths: one path connects to the superior vena cava reflux vessel branch, and the other path connects to the inferior vena cava reflux vessel branch. The gas portion of the main compliant cavity and the auxiliary compliant cavity are connected through a flow-limiting pipeline. The flow-limiting pipeline creates a flow-limiting effect on the paired gas flow, resulting in a slower pressure response speed of the auxiliary compliant cavity relative to the main compliant cavity.
[0010] Furthermore, the superior vena cava reflux vessel branches of the venous vessel module include the jugular vein, subclavian vein, and superior vena cava vessels; the inferior vena cava reflux vessel branches include the inferior vena cava, common iliac vein, renal vein, and hepatic vein vessels; vascular interventional pathways are provided at the jugular vein and common iliac vein for instrument delivery.
[0011] Furthermore, the collection cavity includes an upper limb collection cavity and a lower limb collection cavity. The upper limb collection cavity is connected to the jugular vein and the subclavian vein; the lower limb collection cavity is connected to the common iliac vein, the renal vein, and the hepatic vein.
[0012] Furthermore, the damping module includes a sealed cavity and a porous medium structure. When the fluid passes through the porous medium structure, it forms a distributed flow resistance to dissipate energy from flow disturbances.
[0013] Furthermore, the throttle valve changes the flow distribution ratio by adjusting the flow area of the two branches connecting the superior vena cava and the inferior vena cava through the arterial blood vessel compliance simulation component; after adjustment by the throttle valve, the flow ratio of the superior vena cava to the inferior vena cava is 1:(1.5-3).
[0014] Furthermore, the bellows assembly of the right atrial simulation component includes a support, a bellows, a spring, and a guide rod; a limit block is provided on the guide rod to limit the minimum volume of the bellows.
[0015] Furthermore, the collapsible venous segment is positioned between the venous vessel compliance simulation component and the venous vessel module, or between the right atrial simulation component and the venous vessel compliance simulation component. When the intraluminal pressure is lower than a preset threshold, the fluid backflow is restricted by reducing the effective flow area, thereby preventing excessive negative pressure from being generated in the venous vessel.
[0016] Furthermore, the collapsible venous segment includes a flexible conduit that maintains basic patency within the normal operating pressure range, while collapsing locally when the intraluminal pressure is below a preset threshold, creating a nonlinear impedance to the fluid and achieving passive limitation of non-physiological negative pressure in the venous circuit.
[0017] The beneficial effects of this invention are: (1) In this invention, arterial blood vessel compliance simulation components and venous blood vessel compliance simulation components are respectively set up upstream and downstream of the venous blood vessel module. This allows the pulsating pressure generated by the right heart to be absorbed and buffered in stages in the two sets of compliance chambers, thereby reducing the propagation amplitude of pressure waves in the circulatory loop and reducing the impact of right heart pressure fluctuations on the venous side system. Compared with a single compliance chamber structure, this invention effectively suppresses pressure fluctuations of different frequency components and avoids non-physiological pressure oscillations or negative pressure phenomena on the venous side.
[0018] (2) The circulatory loop of the present invention is provided with a collapsible venous segment, which can prevent the venous vessels from deviating from the physiological value due to excessive negative pressure generated by the strong suction force of the right heart, and has high simulation accuracy. Attached Figure Description
[0019] To more clearly illustrate the specific embodiments of the present invention, the accompanying drawings used in the specific embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For those skilled in the art, other drawings can be obtained based on these drawings without creative effort.
[0020] Figure 1 This is a schematic diagram of the systemic venous simulation system according to an embodiment of the present invention.
[0021] Figure 2A This is a schematic diagram of a right ventricular simulation component according to an embodiment of the present invention.
[0022] Figure 2B This is a partial cross-sectional view of the right ventricular simulation component according to an embodiment of the present invention.
[0023] Figure 3A This is a schematic diagram of an arterial compliance simulation component according to an embodiment of the present invention.
[0024] Figure 3B This is a schematic diagram from another perspective of the arterial compliance simulation component according to an embodiment of the present invention.
[0025] Figure 4 This is a schematic diagram of the venous blood vessel module according to an embodiment of the present invention.
[0026] Figure 5A This is a schematic diagram of the damping module according to an embodiment of the present invention.
[0027] Figure 5B This is an exploded schematic diagram of the damping module according to an embodiment of the present invention.
[0028] Figure 6A This is a schematic diagram of a collapsible venous segment according to an embodiment of the present invention.
[0029] Figure 6B This is a schematic diagram of the structure of a collapsible venous segment according to another embodiment of the present invention.
[0030] Figure 7A This is a schematic diagram of a venous compliance simulation component according to an embodiment of the present invention.
[0031] Figure 7B This is a schematic diagram from another perspective of the venous compliance simulation component according to an embodiment of the present invention.
[0032] Figure 8 This is a schematic diagram of a right atrial simulation component according to an embodiment of the present invention.
[0033] Figure 9 This is a simulated renal vein pressure waveform in an embodiment of the present invention. Detailed Implementation
[0034] The embodiments of the present invention will now be described in detail with reference to the accompanying drawings. However, these embodiments are not limited to the present invention, and any structural, methodological, or functional modifications made by those skilled in the art based on these embodiments are included within the scope of protection of the present invention.
[0035] like Figure 1 The present invention provides a systemic circulation venous simulation system, which includes a right ventricle simulation component 1, an arterial blood vessel compliance simulation component 2, a venous blood vessel module 3, a damping module 4 (41, 42), a throttle valve 5 (51, 52), a collapsible venous segment 6, a venous blood vessel compliance simulation component 7, a right atrium simulation component 8, a drive module 9 (91, 92), and a data acquisition module 10.
[0036] Referring to Figure 2, the right ventricular simulation component 1 of this embodiment includes a pulsatile pump 11, a drive chamber 12, and a right ventricular model 13. The drive chamber 12 is equipped with a tricuspid valve simulator 121, a pulmonary valve simulator 122, a pagoda connector 123, a water filling valve 124, and a venting valve 125. The drive chamber 12 is connected to the right atrial simulation component 8 via the tricuspid valve simulator 121, to the arterial compliance simulation component 2 via the pulmonary valve simulator 122, and to the pulsatile pump 11 via the pagoda connector 123. The right ventricular model 13 of this embodiment is placed inside the drive chamber 12 and has an inlet 131 and an outlet 132, which are connected to the tricuspid valve simulator 121 and the pulmonary valve simulator 122, respectively. The periodic contraction and relaxation of the right ventricular model 13 can directionally pump the fluid inside the right atrial simulation component 8 into the arterial compliance simulation component 2. The tricuspid valve simulator 121 and pulmonary valve simulator 122 of this embodiment are internally equipped with one-way valves (not shown in the figure). These can be ordinary tubular check valves, mechanical valves, bioprosthetic valves, or polymer valves, methods well known in the art. Pure water is filled between the right ventricular model 13 and the drive chamber 12. Pure water can be filled between the drive chamber 12 and the right ventricular model through the water filling valve 124 at the top of the drive chamber 12. The venting valve 125 is used to release air during the water filling process. The right ventricular model of this embodiment has a relatively large thickness in the thickness direction, exhibiting significant elastic deformation during pulsation. Changes in thickness can reflect the influence of left ventricular preload and afterload variations on ventricular volume. This characteristic can simulate the compensatory capacity (Frank-Starling mechanism) of the human native heart, improving the simulation accuracy of the testing platform.
[0037] The pulse pump 11 of this invention can generate biomimetic pulsating blood flow according to different frequencies, stroke volumes, and systolic-diastolic time ratios. This pulsating flow is delivered to the drive chamber 12 via the pagoda connector 123. The reciprocating motion of the internal piston periodically changes the volume of pure water within the chamber, utilizing the incompressibility of pure water to drive the right ventricular model's contraction and relaxation, thus simulating the hemodynamic states of different heart failure patients. The pulse pump used in this invention can be the Vitro Super Pump, a widely used pulse pump in the field. The Vitro Super Pump is a digitally controlled piston pump that can generate physiological cardiac blood flow and has high scalability. This invention connects the Vitro Super Pump to the drive chamber, enabling the right ventricular model to generate biomimetic pulsating flow.
[0038] The arterial compliance simulation component 2 of this invention adopts a parallel gas-liquid composite compliance structure, including a main compliance chamber 21, a secondary compliance chamber 22, and a pressure controller 23. Referring to Figure 3, the main compliance chamber has four pagoda-shaped connectors and a pressure measuring line at its bottom, and a pneumatic interface and a vent valve at its top. The secondary compliance chamber has a pagoda-shaped connector at its bottom and two pneumatic interfaces at its top. Interface 211 at the bottom of the main compliance chamber is connected to the upstream right ventricle simulation component 1, interface 212 is connected to a branch of the superior vena cava return vessel 33, interface 213 is connected to a branch of the inferior vena cava return vessel 34, and interface 214 is connected to interface 221 at the bottom of the secondary compliance chamber. Liquids in both chambers can flow freely. A pressure measuring line 215 is located at the bottom of the main compliance chamber for measuring the pressure within the main compliance chamber. The pneumatic interface 216 at the top of the main compliance chamber is connected to the pneumatic interface 222 at the top of the auxiliary compliance chamber, forming a parallel configuration between the two chambers. In this embodiment, the gas portions of the main compliance chamber and the auxiliary compliance chamber are connected through a pipe with a small cross-sectional area, which has a flow-limiting effect. This makes the response speed of the auxiliary compliance chamber to pressure changes slower than that of the main compliance chamber, thereby forming a graded compliance structure in the system and effectively weakening the transient impact of right ventricular pulsation pressure on the venous return system. A PVC air pipe with an outer diameter of 8mm can be used to connect the gas portions of the two chambers. The vent valve 217 at the top of the main compliance chamber is used for venting during pre-filling of the test liquid. The pneumatic interface 223 at the top of the auxiliary compliance chamber is used to connect to the pressure controller 23 to limit the pressure of the arterial blood vessel compliance chamber. The pressure controller 23 can adjust the internal pressure of the arterial blood vessel compliance simulation component 2 in real time when energized. In practical applications, the congestion state of the venous blood vessel module 3 of different patients can be simulated by adjusting the pressure of the arterial blood vessel compliance simulation component 2. The pressure controller 23 in this embodiment of the invention can be selected from the PCD series pressure controller of ALICAT, and is not limited thereto.
[0039] In this embodiment of the invention, when the right ventricular simulation component 1 generates pulsating flow, the instantaneously increased fluid volume enters the main arterial compliance chamber 21 to receive the pulsating blood flow generated by the right ventricle, compressing the upper gas to produce a larger volume response under pressure changes, thereby providing primary buffering for the periodic pressure waves output by the right ventricle. The auxiliary compliance chamber 22 of this embodiment is connected to the main compliance chamber via an 8mm trachea. Its structure is similar to the main compliance chamber, also containing compressible gas, but its volume lags slightly behind the main compliance chamber, providing further compliance compensation for the fluid regulated by the main compliance chamber. Through the synergistic effect of the main and auxiliary compliance chambers, the arterial compliance simulation component 2 forms a distributed volumetric compliance characteristic, reducing the pressure response amplitude of a single compliance chamber under transient conditions, improving the buffering stability of right ventricular pressure fluctuations, and thus reducing the transmission of pressure fluctuations to the downstream venous module. This makes the pressure fluctuations entering the downstream venous system more stable. In different implementations, the main compliance cavity and the auxiliary compliance cavity can be configured as a partially parallel structure or an equivalent compliance connected structure, and their overall equivalent compliance degree can be adjusted according to the test requirements.
[0040] See Figure 4 The venous vessel module 3 of this invention includes an upper limb fluid collection chamber 31, a lower limb fluid collection chamber 32, a superior vena cava return vessel 33, an inferior vena cava return vessel 34, and a vena cava confluence conduit 35. The superior vena cava return vessel 33 includes the jugular vein 331, the subclavian vein 332, and the superior vena cava 333. The inferior vena cava return vessel 34 includes the common iliac vein 341, the renal vein 342, the hepatic vein 343, and the inferior vena cava 344. The upper limb fluid collection chamber 31 communicates with the jugular vein 331 and the subclavian vein 332, and the lower limb fluid collection chamber 32 communicates with the common iliac vein 341, the renal vein 342, and the hepatic vein 343. The venous vessel module is manufactured using injection molding or 3D printing technology, and the material is biomimetic silicone, which has conformability similar to native arterial vessels. Each branch of the venous vessel in this invention is equipped with a manual throttling valve for adjusting the flow distribution of each branch. In this embodiment of the invention, the superior vena cava reflux vessel 33 is connected upstream to the main compliant cavity 21 of the artery via a first throttling valve 51 and a first damping module 41, and the inferior vena cava reflux vessel 34 is connected upstream to the main compliant cavity 21 of the artery via a second throttling valve 52 and a second damping module 42. The vena cava confluence conduit 35 is connected to the collapsible venous segment 6.
[0041] In this embodiment of the invention, the jugular vein 331 and common iliac vein 341 of the venous vascular module 3 are both provided with vascular interventional pathways 3311 and 3411 for delivering vena cava interventional devices into the superior and inferior vena cava. In this embodiment of the invention, pressure measuring lines are provided at the confluence of the jugular vein 331, subclavian vein 332, common iliac vein 341, renal vein 342, hepatic vein 343, inferior vena cava 344, and vena cava for pressure detection. See [link to relevant documentation]. Figure 4 P1, P2, P3, P4, P5, P6, and P7 are listed. Flow sensors are installed at each branch of the superior vena cava reflux vessel 33 and the inferior vena cava reflux vessel 34. See [reference needed]. Figure 4 F1, F2, F3, F4, F5, F6, and F7. Blood pressure and flow signals can be used to assess venous hemodynamics.
[0042] This embodiment of the invention includes two damping modules. The first damping module 41 is disposed on the branch of the arterial compliance simulation component 2 that connects to the superior vena cava return vessel 33, and the second damping module 42 is disposed on the branch of the arterial compliance simulation component 2 that connects to the inferior vena cava return vessel 34. Referring to Figure 5, the first damping module 41 includes a sealed cavity 411 and a porous medium structure. In this embodiment of the invention, the sealed cavity 411 is composed of an upper cover plate 4111, a sealing ring 4112, and a bottom cavity 4113. The porous medium can be a sponge 412. The sealed cavity 411 is provided with an inflow port 4114, an outflow port 4115, an exhaust valve 4116, and a drain valve 4117. The inflow interface 4114 is connected to the upstream arterial compliance simulation component 2, and the outflow interface 4115 is connected to the venous module 3 via the throttle valve 51. The spongy body 412 is disposed inside the cavity 411. Through its porous media structure, the spongy body generates distributed resistance during fluid flow, dissipating energy and simulating the damping effect of the peripheral vascular bed on blood flow. This effect is similar to the obstruction and energy dissipation effect of capillaries and microvenous networks on blood flow in the human circulatory system, improving the physiological similarity of the in vitro testing system in terms of venous pressure stability. The second damping module 42 has a similar structure to the first damping module 41, and will not be described further here.
[0043] In this embodiment of the invention, the arterial compliance simulation component 2 buffers the periodic pressure waves output by the right ventricular simulation component 1 through volume changes, while the damping module 4 further dissipates energy from the compliant fluid through flow resistance. The two components are arranged sequentially along the fluid flow direction, enabling the system to simultaneously possess both compliance and damping capabilities. This more realistically simulates the coupling characteristics of arterial elasticity and peripheral resistance in the human circulatory system, avoiding pressure fluctuations caused by a single adjustment structure.
[0044] This invention includes two throttling valves. A first throttling valve 51 is disposed between a first damping module 41 and a superior vena cava return vessel 33, and a second throttling valve 52 is disposed between a second damping module 42 and an inferior vena cava return vessel 34. By changing the flow cross-sectional area of the two branches, the flow distribution ratio is adjusted to control the flow ratio of fluid in different branches to conform to the physiological characteristics of human veins. After adjustment by the throttling valves, the flow ratio between the superior vena cava return vessel and the inferior vena cava return vessel is in the range of 1:(1.5-3).
[0045] In this embodiment of the invention, the collapsible venous segment 6 is disposed between the venous vessel module 3 and the venous vessel compliance simulation component 7, and is a tubular component with a flexible wall structure. The collapsible venous segment is preferably made of a large-diameter, thin-walled material, so that it does not undergo significant elastic tensile or compressive deformation within the normal working pressure range, and remains patent under physiological venous pressure conditions. The thin-walled material used in this embodiment of the invention is EVA, but it is not a limitation. See also Figure 6A The collapsible venous segment 6 of this embodiment includes an upstream interface 61, a downstream interface 62, and a collapsible tubular component 63. When the right atrial simulation component 8 generates strong suction or a sudden change in reflux resistance, the collapsible venous segment 6 preferentially deforms. Especially when the internal pressure is lower than atmospheric pressure, the adaptive reduction of the flow area restricts the continued reflux of fluid, thereby avoiding excessive negative pressure in the venous vessels. By setting the collapsible venous segment 6, passive limitation of non-physiological negative pressure in the venous circuit can be achieved without introducing additional control devices, allowing the test system to maintain a stable venous pressure state under different cardiac outputs and different reflux conditions. The collapse behavior of the collapsible venous segment 6 of this embodiment is mainly determined by its diameter, wall thickness, and structural stability characteristics, rather than relying on significant elastic tensile deformation of the material. Its material elastic parameters do not constitute a substantial limitation on this embodiment.
[0046] See Figure 6BIn another embodiment of the present invention, the collapsible venous segment 6 further includes a pressure chamber 64, with an upstream interface 61 and a downstream interface 62 threadedly connected to the pressure chamber 64. A collapsible tubular component 63 is disposed inside the pressure chamber 64 and communicates with the upstream interface 61 and the downstream interface 62. The pressure chamber 64 includes an upper cover plate 641, a bottom chamber 642, and a sealing ring 643. A pneumatic interface 65 is disposed at the top of the upper cover plate 641, which communicates with an external air supply system and can control the internal pressure of the pressure chamber 64 to remain constant. When the pressure in the circuit drops below a preset threshold, the wall of the collapsible tubular component partially collapses under external pressure or structural instability failure, thereby reducing the effective flow cross-sectional area and restricting the continued backflow of fluid. In other embodiments of the present invention, the collapsible venous segment 6 may also be disposed between the venous vessel compliance simulation component 7 and the right atrial simulation component 8.
[0047] The venous compliance simulation component 7 of this embodiment is structurally similar to the arterial compliance simulation component 2, including a main venous compliance cavity 71 and a secondary venous compliance cavity 72. Referring to Figure 7, the main venous compliance cavity 71 has three pagoda-shaped connectors, a drain valve, and a pressure measuring line at its bottom, and a pneumatic interface and an exhaust valve at its top. The secondary venous compliance cavity 72 has a pagoda-shaped connector at its bottom and a pneumatic interface and a water filling valve at its top. Interface 711 of the main venous compliance cavity is connected to the right atrial simulation component 8, interface 712 is connected to the venous vessel module 3 via a collapsible venous segment 6, and interface 713 is connected to interface 721 of the secondary venous compliance cavity. The drain valve 714 is used to drain the liquid from the circulation line after the experiment, and the pressure measuring line 715 is used to connect a pressure sensor to measure pressure. The pneumatic interface 716 at the top of the main venous compliance cavity is connected to interface 722 at the top of the secondary venous compliance cavity, and the two cavities are configured in parallel. The water injection valve 723 at the top of the venous compliance chamber in this embodiment of the invention is used to inject test liquid into the entire circulation loop. The test liquid is animal blood or a water-glycerol mixture. The vent valve 717 is used for venting during pre-filling of the test liquid. During the periodic filling and emptying of the right atrial simulation component 8, the venous return pressure fluctuates accordingly. The venous compliance simulation component 7 buffers the fluid volume change before entering the right atrium through the compression and rebound of the upper gas, thereby reducing the transmission of right atrial pressure fluctuations to the venous module. The two venous compliance chambers arranged in parallel in this embodiment of the invention can simultaneously participate in volume regulation, so that transient fluid volume changes are dispersed between the two compliance chambers, thereby reducing the amplitude of instantaneous pressure changes borne by a single compliance chamber.
[0048] See Figure 8The right atrial simulation component 8 of this embodiment includes a cavity 81 and a bellows assembly 82. The cavity 81 includes an inlet port 811, an outlet port 812, and a pressure measuring line 813. The inlet port 811 is connected to a venous compliance simulation component 7, and the outlet port 812 is connected to a right ventricular simulation component 1. The pressure measuring line 813 is used to connect a pressure sensor to measure the pressure of the right atrial simulation component 8 in real time. The bellows assembly 82 includes a support 821, a bellows 822, a spring 823, a guide rod 824, and an exhaust pipe 825. The volume and shape changes of the bellows 822 and the spring 823 simulate the filling state of the right atrium, receiving venous return. An exhaust valve 826 is used to exhaust air when the circulatory system is pre-filled with test fluid. A limit block 8241 is provided on the guide rod 824 to limit excessive volume reduction of the right atrial simulator during emptying or aspiration. When the right atrial simulation component 8 is affected by the suction of the right ventricular simulation component 1 or the decrease in venous return pressure in the circulation loop, the limiting block 8241 can limit the minimum effective volume of the right atrial simulator. By setting the limiting structure, the test system can maintain a stable venous pressure state under different cardiac output and different return conditions, and work in conjunction with the collapsible venous segment to achieve graded negative pressure inhibition.
[0049] The drive module 9 in this embodiment has ventricular drive control, gas supply control, and electric throttling valve control functions. It can drive the pulse pump to generate biomimetic pulsating blood flow according to different operating frequencies, stroke volume, and systolic-diastolic time ratios, driving the right ventricle to simulate different heart failure states through systolic and diastolic movements. The drive module 9 can adjust the pressure and compliance of the arterial blood vessel compliance simulation component through a pressure controller, and change the flow distribution ratio by controlling the throttling valve 5 to adjust the flow area of the two branches connecting the superior vena cava and inferior vena cava return vessels of the arterial blood vessel compliance simulation component.
[0050] The data acquisition module 10 of this embodiment measures pressure and flow changes at preset locations in the circulatory system using pressure and flow sensors to monitor hemodynamic status in real time. The data acquisition module in this embodiment is a PowerLab from ADInstruments, equipped with a tubular flow meter (T401, Transonic System) and a clip-on ultrasonic flow sensor for flow measurement. Pressure signals in the circuit are measured using a bridge amplifier and a liquid-filled pressure sensor (MLT1199, ADInstruments, Australia). The Transonic flow meter and bridge amplifier can record data via an instrument interface and the PowerLab data acquisition system. Data analysis is performed using LabChart physiological data analysis software. See also... Figure 9 The renal venous pressure waveform of the simulated heart failure patient collected in this embodiment of the invention has high simulation accuracy.
[0051] The in vitro simulation system of this invention can realistically simulate the compliance and flow-limiting characteristics of the venous system, and can be used for in vitro testing of vena cava intervention devices, guiding animal experiments and clinical applications, with the following excellent effects: (1) In this invention, arterial blood vessel compliance simulation components and venous blood vessel compliance simulation components are respectively set up upstream and downstream of the venous blood vessel module. This allows the pulsating pressure generated by the right heart to be absorbed and buffered in stages in the two sets of compliance chambers, thereby reducing the propagation amplitude of pressure waves in the circulatory loop and reducing the impact of right heart pressure fluctuations on the venous side system. Compared with a single compliance chamber structure, this invention effectively suppresses pressure fluctuations of different frequency components and avoids non-physiological pressure oscillations or negative pressure phenomena on the venous side.
[0052] (2) The circulatory loop of the present invention is provided with a collapsible venous segment, which can prevent the venous blood vessel module from deviating from the physiological value due to excessive negative pressure generated by the strong suction force of the right heart, and has high simulation accuracy.
[0053] The above description is merely a preferred embodiment of the present invention, but the scope of protection of the present invention is not limited thereto. Any variations or substitutions that can be easily conceived by those skilled in the art within the scope of the technology disclosed in the present invention should be included within the scope of protection of the present invention. Therefore, the scope of protection of the present invention should be determined by the scope of the claims.
Claims
1. A system for simulating venous return in a body circulation, characterized in that It includes a right ventricular simulation component, an arterial compliance simulation component, a venous module, a damping module, a throttle valve, a collapsible venous segment, a venous compliance simulation component, a right atrial simulation component, a drive module, and a data acquisition module; The right ventricular simulation component includes a pulsatile pump, a drive chamber, and a right ventricular model, used to simulate the blood pumping function of the right ventricle. The arterial compliance simulation component includes a main compliance chamber, an auxiliary compliance chamber, and a pressure controller. It is connected upstream to the right ventricle simulation component and downstream to the venous module. It is used to provide volume buffering, simulate the elastic energy storage characteristics of the arterial system, and reduce the direct transmission of periodic pressure waves generated by the right ventricle to the downstream circuit. The venous vessel module includes a collection chamber, a superior vena cava return vessel, an inferior vena cava return vessel, and a vena cava confluence conduit. The upstream of the superior vena cava return vessel and the inferior vena cava return vessel are respectively connected to different outlets of the arterial vessel compliance simulation component through the collection chamber. The vena cava confluence conduit is connected to the venous vessel compliance simulation component via a collapsible venous segment. The damping module includes a first damping module and a second damping module, which are respectively set on the two branches of the arterial blood vessel compliance simulation component that connect the superior vena cava return vessels and the inferior vena cava return vessels, to simulate the obstructive effect of the microcirculatory vascular bed on blood flow in the venous return path. The throttling valve includes a first throttling valve and a second throttling valve, which are respectively disposed between the first damping module and the second damping module and the venous blood vessel module for adjusting the flow distribution; The collapsible venous segment automatically limits the flow by collapsing itself, preventing excessive negative pressure in the venous system and stabilizing the venous return system; The upstream of the venous vessel compliance simulation component is connected to the venous vessel module, and the downstream is connected to the right atrial simulation component, which is used to reduce the transmission of right atrial pressure fluctuations to the venous vessels. The right atrial simulation component includes a cavity and a bellows assembly, which reflects the right atrial filling state through internal volume changes and simulates venous blood return. The drive module is used to control the right ventricular simulation component to generate pulsating biomimetic blood flow, simulating cardiac output under different heart failure states; The data acquisition module is used to measure the pressure and flow signals at different preset points in the circulatory loop, and to evaluate the hemodynamic state of the circulatory system in real time.
2. The systemic venous simulation system of claim 1, wherein, The venous blood vessel compliance simulation component has the same structure as the arterial blood vessel compliance simulation component; the bottom of the main compliance cavity and the auxiliary compliance cavity of the arterial blood vessel compliance simulation component contain test liquid, and the top contains compressible gas; The bottom liquids of the main compliance chamber and the auxiliary compliance chamber are interconnected, and the top air is interconnected, forming a parallel distributed compliance structure; the pressure controller is connected to the auxiliary compliance chamber and changes the compliance of the arterial blood vessel compliance simulation component and the pressure of the venous blood vessel by adjusting the gas pressure.
3. The systemic venous simulation system of claim 2, wherein, The main compliant cavity is connected to the venous vessel module in two ways: one way connects to the superior vena cava reflux vessel branch, and the other way connects to the inferior vena cava reflux vessel branch. The gas portion of the main compliant cavity and the auxiliary compliant cavity are connected through a flow-limiting pipeline. The flow-limiting pipeline creates a flow-limiting effect on the paired gas flow, so that the auxiliary compliant cavity has a slower pressure response speed relative to the main compliant cavity.
4. The systemic circulation venous simulation system according to claim 1, characterized in that, The superior vena cava reflux vessel branches of the venous vascular module include the jugular vein, subclavian vein, and superior vena cava vessels; the inferior vena cava reflux vessel branches include the inferior vena cava, common iliac vein, renal vein, and hepatic vein vessels; vascular interventional access is provided at the jugular vein and common iliac vein for instrument delivery.
5. The systemic circulation venous simulation system according to claim 1, characterized in that, The collection chamber includes an upper limb collection chamber and a lower limb collection chamber. The upper limb collection chamber is connected to the jugular vein and the subclavian vein. The lower limb collection chamber is connected to the common iliac vein, the renal vein, and the hepatic vein.
6. The systemic circulation venous simulation system according to claim 1, characterized in that, The damping module includes a sealed cavity and a porous medium structure. When the fluid passes through the porous medium structure, it forms a distributed flow resistance, which dissipates the energy of the flow disturbance.
7. The systemic circulation venous simulation system according to claim 1, characterized in that, The throttle valve changes the flow distribution ratio by adjusting the flow area of the two branches connecting the superior vena cava and the inferior vena cava through the arterial blood vessel compliance simulation component; after adjustment by the throttle valve, the flow ratio of the superior vena cava to the inferior vena cava is 1:(1.5-3).
8. The systemic circulation venous simulation system according to claim 1, characterized in that, The bellows assembly of the right atrial simulation component includes a support, a bellows, a spring, and a guide rod; a limit block is provided on the guide rod to limit the minimum volume of the bellows.
9. The systemic circulation venous simulation system according to claim 1, characterized in that, The collapsible venous segment is positioned between the venous vessel compliance simulation component and the venous vessel module, or between the right atrial simulation component and the venous vessel compliance simulation component. When the intraluminal pressure is lower than a preset threshold, the fluid backflow is restricted by reducing the effective flow area, thus preventing excessive negative pressure from being generated in the venous vessel.
10. The systemic circulation venous simulation system according to claim 9, characterized in that, The collapsible venous segment includes a flexible tubing that maintains basic patency within the normal operating pressure range, but collapses locally when the intraluminal pressure is below a preset threshold, creating a nonlinear impedance to the fluid and thus passively limiting non-physiological negative pressure in the venous circuit.
